Reteplase: Thrombolytic Therapy for Heart Attack Treatment

Summary of Key Points

Reteplase is a medication used in thrombolytic therapy to treat conditions such as heart attacks and blood clots. It works by breaking down clots that block blood flow to critical organs. Reteplase is typically administered in emergency situations, and it’s essential to follow your healthcare provider’s instructions closely. Always consult a doctor before starting or adjusting your dose. Telemedicine services can provide quick access to a healthcare provider for guidance on Reteplase dosage and administration.

Names of Medication

US Brand Name: Retavase

Generic Name: Reteplase

The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. The generic name is listed in parentheses.

Pharmacologic Category

Thrombolytic Agent

Other medications in this category include:

1. Alteplase (Activase)
2. Tenecteplase (TNKase)
3. Streptokinase

Reteplase Dosage

Reteplase is used to treat several serious conditions. Below are the recommended doses for adults. Always consult your healthcare provider before making any changes to your dose. You can also connect with one of our telemedicine providers for personalized advice on Reteplase dosage and administration.

Myocardial Infarction (Heart Attack)

Dose: 10 units IV bolus, followed by a second 10-unit dose 30 minutes later.

This treatment is typically administered in emergency settings to dissolve blood clots causing a heart attack.

Acute Coronary Syndrome

Dose: Same as myocardial infarction—10 units IV bolus, followed by a second 10-unit dose 30 minutes later.

ST-Elevation Myocardial Infarction (STEMI)

Dose: 10 units IV bolus, followed by a second 10-unit dose 30 minutes later.

Pulmonary Embolism

Dose: Off-label use; consult your healthcare provider for specific dosing.

Deep Vein Thrombosis (DVT)

Dose: Off-label use; consult your healthcare provider for specific dosing.

Ischemic Stroke

Dose: Off-label use; consult your healthcare provider for specific dosing.

Thrombotic Thrombocytopenic Purpura (TTP)

Dose: Off-label use; consult your healthcare provider for specific dosing.

Peripheral Arterial Occlusion

Dose: Off-label use; consult your healthcare provider for specific dosing.

Coronary Artery Disease

Dose: Off-label use; consult your healthcare provider for specific dosing.

Atrial Fibrillation

Dose: Off-label use; consult your healthcare provider for specific dosing.

Dosage Forms and Strengths

Injection: 10 units (as lyophilized powder for reconstitution)

Reteplase Administration Instructions

Reteplase is administered by a healthcare professional, typically in a hospital or emergency setting. It is given as an intravenous (IV) bolus injection. The medication is reconstituted (mixed) with a sterile solution before injection. Follow all instructions from your healthcare provider and seek immediate medical attention if you experience any unusual symptoms. If you have questions about your treatment, our telemedicine providers are available to assist you with Reteplase administration and any concerns.

Adverse Reactions and Reteplase Side Effects

Like all medications, Reteplase can cause side effects. Some are more common, while others are rare but serious. Contact your healthcare provider if you experience any of the following:

1. Bleeding (Common): Reteplase can increase the risk of bleeding, including internal bleeding. Watch for unusual bruising, nosebleeds, or blood in your urine or stool.
2. Hypotension (Low Blood Pressure) (Common): You may feel lightheaded or dizzy. If this happens, sit or lie down and contact your healthcare provider.
3. Allergic Reactions (Rare): Some people may experience an allergic reaction, including rash, itching, or difficulty breathing. Seek immediate medical attention if this occurs.
4. Stroke (Rare but Serious): In rare cases, Reteplase can cause a stroke. Symptoms include sudden weakness, confusion, or difficulty speaking. Call 911 immediately if you experience these symptoms.

Contraindications for Reteplase

A contraindication is a specific situation or condition where a medication should not be used because it may cause harm. Reteplase has several contraindications, meaning there are certain conditions where taking this medication could be dangerous. Below is a list of contraindications for Reteplase and why it is not recommended in these cases:

1. Active internal bleeding: Reteplase breaks down blood clots, so if you’re already bleeding internally, this medication could worsen the bleeding.
2. Recent stroke (within 3 months): If you’ve had a recent stroke, especially one caused by brain bleeding (hemorrhagic stroke), Reteplase could increase the risk of further bleeding in the brain.
3. Severe uncontrolled high blood pressure: High blood pressure increases the risk of bleeding, and Reteplase could exacerbate this, leading to complications like stroke or internal bleeding.
4. Recent major surgery or trauma (within 3 months): If you’ve had major surgery or injury, your body may still be healing, and Reteplase could cause excessive bleeding.
5. Known bleeding disorders: If you have a condition affecting your blood’s ability to clot, such as hemophilia, Reteplase could lead to severe, uncontrolled bleeding.
6. History of intracranial hemorrhage: If you’ve had brain bleeding in the past, Reteplase could increase the risk of recurrence.

If you have any of these conditions, it’s important to discuss them with your healthcare provider. Our telemedicine providers are available to help you determine if Reteplase is safe for you.

Drug to Drug Interactions

Reteplase can interact with other medications, potentially increasing side effects or reducing its effectiveness. Below is a list of medications that may interact with Reteplase:

1. Anticoagulants (e.g., Warfarin, Heparin): These blood thinners, when used alongside Reteplase, can significantly raise the risk of severe bleeding.
2. Antiplatelet drugs (e.g., Clopidogrel [Plavix], Aspirin): These medications help prevent blood clots, but combining them with Reteplase can also increase the likelihood of bleeding.
3. Nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., Ibuprofen [Advil], Naproxen [Aleve]): NSAIDs can heighten the risk of gastrointestinal bleeding, which may be further exacerbated by Reteplase.
4. Selective serotonin reuptake inhibitors (SSRIs) (e.g., Sertraline [Zoloft], Fluoxetine [Prozac]): These antidepressants may increase the risk of bleeding when taken with Reteplase.

Always inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Our telemedicine team can help review your medications to ensure no harmful interactions occur.

Reteplase in Pregnancy

Is it Safe to Take Reteplase When Pregnant?

Reteplase is classified as a Category C medication for pregnancy, meaning that while no well-controlled studies have been conducted in pregnant women, animal studies have shown some risk to the fetus. Reteplase should only be used during pregnancy if the potential benefits outweigh the risks. It is crucial to discuss your options with your healthcare provider if you are pregnant or planning to become pregnant. Our telemedicine providers can assist you in making an informed decision about your treatment during pregnancy.

Reteplase While Breastfeeding

Is it Safe to Take Reteplase While Breastfeeding?

There is limited information on whether Reteplase passes into breast milk. Due to potential risks, it is generally recommended to avoid breastfeeding while taking Reteplase or to discuss alternative treatments with your healthcare provider. If you are breastfeeding and require treatment, our telemedicine providers can help you explore safer options.

Estimated Cost of Reteplase

The estimated cost of a single dose of Reteplase without insurance ranges from $2,500 to $3,000, depending on the pharmacy and location. A GoodRX coupon may help reduce the cost, but it’s important to check with your local pharmacy for the most accurate pricing. Since Reteplase is typically used in emergency settings, it is not usually prescribed as a long-term medication.

Possible Alternatives to Reteplase

Depending on the condition being treated, alternative treatments or lifestyle changes may be considered. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are available to discuss these options with you.

1. Myocardial infarction (heart attack): Alternatives include other thrombolytic agents like Alteplase (Activase) or mechanical interventions such as angioplasty. Lifestyle changes, such as quitting smoking, adopting a heart-healthy diet, and engaging in regular exercise, can also help prevent future heart attacks.
2. Acute coronary syndrome: Medications like Aspirin, Beta-blockers, and Statins may be used as alternatives. Lifestyle modifications, including stress reduction, maintaining a healthy weight, and controlling blood pressure, are also important.
3. ST-elevation myocardial infarction (STEMI): Percutaneous coronary intervention (PCI) is often the preferred treatment. Medications like Clopidogrel (Plavix) or Ticagrelor (Brilinta) may also be used.
4. Pulmonary embolism: Alternatives include anticoagulants like Heparin or Warfarin, or in severe cases, surgical removal of the clot.
5. Deep vein thrombosis (DVT): Anticoagulants such as Rivaroxaban (Xarelto) or Apixaban (Eliquis) are commonly used. Compression stockings and regular physical activity can also help prevent DVT.
6. Ischemic stroke: Alteplase (Activase) is another thrombolytic agent that may be used. Long-term management includes controlling blood pressure, managing cholesterol levels, and making lifestyle changes such as improving diet and increasing physical activity.
7. Thrombotic thrombocytopenic purpura (TTP): Plasma exchange is the primary treatment, and immunosuppressive drugs like Rituximab may also be used.
8. Peripheral arterial occlusion: Treatment options include angioplasty, stenting, or bypass surgery. Lifestyle changes, such as quitting smoking and managing diabetes, are also important.
9. Coronary artery disease (CAD): Medications like Statins, Beta-blockers, and Aspirin are commonly used. Lifestyle changes, including a heart-healthy diet, regular exercise, and smoking cessation, are crucial.
10. Atrial fibrillation: Anticoagulants like Warfarin or newer agents like Apixaban (Eliquis) are often prescribed. Electrical cardioversion or catheter ablation may also be considered.

Recent Updates on Reteplase Research

Recent studies have compared Reteplase with other thrombolytic agents, such as Alteplase, for treating acute ischemic stroke and myocardial infarction. Some research suggests that Reteplase may have a faster onset of action, which could be beneficial in time-sensitive conditions like heart attacks. However, more studies are needed to confirm these findings. Additionally, ongoing research is exploring the use of Reteplase in combination with newer anticoagulants to improve outcomes in patients with pulmonary embolism and deep vein thrombosis.

It’s important to stay informed about the latest research and discuss any new findings with your healthcare provider. Our telemedicine providers are available to answer any questions you may have about your treatment options.

James Kingsley

Learn More